ULTRASOUND EVALUATION OF OVARIAN ACTIVITY UNDER ORAL-CONTRACEPTIVES
ULTRASOUND EVALUATION OF OVARIAN ACTIVITY UNDER ORAL-CONTRACEPTIVES
复制标题
DOI：
10.1016/0010-7824(93)90025-3
复制
发表时间：
1993-06-01
期刊：
影响因子：
2.9
通讯作者：
SKOUBY, SO
中科院分区：
文献类型：
--
作者：
HOOGLAND, HJ;SKOUBY, SO
为了减少副作用而改变避孕药成分的趋势可能会导致卵巢活动增加。这可能会降低可靠性。因此，一种非侵入性的方法来监测避孕药对卵巢功能的抑制作用是必要的。本研究的目的是调查诊断超声是否可能是研究避孕药使用期间剩余卵巢活动的首选方法。（30微克炔雌醇（EE）/ 75微克孕二烯酮），前两个月的药丸摄入量进行了广泛的监测与诊断超声。该研究显示，在服用避孕药的第一周内，只需要进行一次超声检查，就可以发现所有相关的卵巢残留活动情况。需要进行随访调查，以更具体地量化这种活动。
The trend towards changing the composition of the contraceptive pill in order to decrease side effects might lead to increased ovarian activity. This may decrease reliability. Therefore, a non-invasive method for monitoring the suppressive effect of the pill on ovarian function is warranted.The aim of the present study was to investigate whether or not diagnostic ultrasound might be the method of choice for studying residual ovarian activity during pill use.In 89 women on a low-dose oral contraceptive (30 mcg ethinyl-estradiol (EE) / 75 mcg gestodene), the first two months of pill-intake were monitored extensively with diagnostic ultrasound. The study revealed that only one ultrasound investigation was needed during the first week of pill intake to discover all relevant cases of residual ovarian activity.Follow-up investigations are needed to quantify this activity more specifically.